Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Shanghai Institute of Medical Imaging, Fudan University, Shanghai, 200032, China.
Biomed Pharmacother. 2021 May;137:111333. doi: 10.1016/j.biopha.2021.111333. Epub 2021 Feb 8.
Immunotherapy that boosts the body's immune system to treat local and distant metastatic tumors has offered a new treatment option for cancer. However, cancer immunotherapy via systemic administration of immunotherapeutic agents often has two major issues of limited immune responses and potential immune-related adverse events in the clinic. Hydrogels, a class of three-dimensional network biomaterials with unique porous structures can achieve local delivery of drugs into tumors to trigger the antitumor immunity, resulting in amplified immunotherapy at lower dosages. In this review, we summarize the recent development of polymer-based hydrogels as drug release systems for local delivery of various immunotherapeutic agents for cancer immunotherapy. The constructions of polymer-based hydrogels and their local delivery of various drugs in tumors to achieve sole immunotherapy, and chemotherapy-, and phototherapy-combinational immunotherapy are introduced. Furthermore, a brief conclusion is given and existing challenges and further perspectives of polymer-based hydrogels for cancer immunotherapy are discussed.
免疫疗法通过增强机体免疫系统来治疗局部和远处转移的肿瘤,为癌症提供了一种新的治疗选择。然而,通过全身给予免疫治疗药物的癌症免疫疗法在临床上常常存在两个主要问题:免疫反应有限和潜在的免疫相关不良事件。水凝胶是一类具有独特多孔结构的三维网络生物材料,可将药物局部递送到肿瘤中以触发抗肿瘤免疫,从而以较低的剂量实现增强的免疫治疗。在这篇综述中,我们总结了聚合物水凝胶作为各种免疫治疗药物的局部递药系统在癌症免疫治疗中的最新进展。介绍了聚合物水凝胶的构建及其在肿瘤中局部递药以实现单一免疫疗法,以及化疗-和光疗联合免疫疗法。此外,还简要总结了聚合物水凝胶在癌症免疫治疗中的现有挑战和进一步展望。
Biomed Pharmacother. 2021-5
Macromol Biosci. 2018-10-10
ACS Appl Mater Interfaces. 2020-2-10
Acta Biomater. 2019-2-13
Chem Soc Rev. 2019-11-11
Angew Chem Int Ed Engl. 2020-9-28
J Hematol Oncol. 2019-11-28
Bioact Mater. 2025-7-25
J Nanobiotechnology. 2025-3-22
Pharmaceutics. 2024-12-27
Naunyn Schmiedebergs Arch Pharmacol. 2025-5
Drug Deliv Transl Res. 2025-5